ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Quadrivalent Influenza Virus Split Vaccine Market Research Report 2025
Published Date: 2025-06-03
|
Report Code: QYRE-Auto-10V16292
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Quadrivalent Influenza Virus Split Vaccine Market Research Report 2023
BUY CHAPTERS

Global Quadrivalent Influenza Virus Split Vaccine Market Research Report 2025

Code: QYRE-Auto-10V16292
Report
2025-06-03
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Hualan Biological Engineering
ADIMMUNE Corporation
Shanghai Institute of Biological Products
SINOVAC BIOTECH
Chongqing Zhifei Biological Products
Jiangsu GDK Biotechnology

Quadrivalent Influenza Virus Split Vaccine Market

The global market for Quadrivalent Influenza Virus Split Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Quadrivalent influenza virus split vaccine refers to an inactivated split influenza vaccine whose vaccine components include A (H3N2) subtype, A (H1N1) pdm09 subtype, and type B Victoria and Yamagata lines.
North American market for Quadrivalent Influenza Virus Split Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Quadrivalent Influenza Virus Split Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Quadrivalent Influenza Virus Split Vaccine include Hualan Biological Engineering, ADIMMUNE Corporation, Jiangsu GDK Biotechnology, Shanghai Institute Of Biological Products, Changchun Lnstitute of Biological Products Co., Ltd., Wuhan Institute of Biological Products Co., Ltd., Sinovac Biotech, Chongqing Zhifei Biological Products, Sanofi Pasteur, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Quadrivalent Influenza Virus Split Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quadrivalent Influenza Virus Split Vaccine.
The Quadrivalent Influenza Virus Split Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Quadrivalent Influenza Virus Split Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Quadrivalent Influenza Virus Split Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Quadrivalent Influenza Virus Split Vaccine Market Report

Report Metric Details
Report Name Quadrivalent Influenza Virus Split Vaccine Market
Segment by Type
  • 0.5mL/Tube
  • Others
Segment by Application
  • Influenza A Virus Prevention
  • Influenza B Virus Prevention
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hualan Biological Engineering, ADIMMUNE Corporation, Jiangsu GDK Biotechnology, Shanghai Institute Of Biological Products, Changchun Lnstitute of Biological Products Co., Ltd., Wuhan Institute of Biological Products Co., Ltd., Sinovac Biotech, Chongqing Zhifei Biological Products, Sanofi Pasteur
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Quadrivalent Influenza Virus Split Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Quadrivalent Influenza Virus Split Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Quadrivalent Influenza Virus Split Vaccine Market report?

Ans: The main players in the Quadrivalent Influenza Virus Split Vaccine Market are Hualan Biological Engineering, ADIMMUNE Corporation, Jiangsu GDK Biotechnology, Shanghai Institute Of Biological Products, Changchun Lnstitute of Biological Products Co., Ltd., Wuhan Institute of Biological Products Co., Ltd., Sinovac Biotech, Chongqing Zhifei Biological Products, Sanofi Pasteur

What are the Application segmentation covered in the Quadrivalent Influenza Virus Split Vaccine Market report?

Ans: The Applications covered in the Quadrivalent Influenza Virus Split Vaccine Market report are Influenza A Virus Prevention, Influenza B Virus Prevention

What are the Type segmentation covered in the Quadrivalent Influenza Virus Split Vaccine Market report?

Ans: The Types covered in the Quadrivalent Influenza Virus Split Vaccine Market report are 0.5mL/Tube, Others

1 Quadrivalent Influenza Virus Split Vaccine Market Overview
1.1 Product Definition
1.2 Quadrivalent Influenza Virus Split Vaccine by Type
1.2.1 Global Quadrivalent Influenza Virus Split Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5mL/Tube
1.2.3 Others
1.3 Quadrivalent Influenza Virus Split Vaccine by Application
1.3.1 Global Quadrivalent Influenza Virus Split Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Influenza A Virus Prevention
1.3.3 Influenza B Virus Prevention
1.4 Global Quadrivalent Influenza Virus Split Vaccine Market Size Estimates and Forecasts
1.4.1 Global Quadrivalent Influenza Virus Split Vaccine Revenue 2020-2031
1.4.2 Global Quadrivalent Influenza Virus Split Vaccine Sales 2020-2031
1.4.3 Global Quadrivalent Influenza Virus Split Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Quadrivalent Influenza Virus Split Vaccine Market Competition by Manufacturers
2.1 Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Quadrivalent Influenza Virus Split Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Quadrivalent Influenza Virus Split Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Date of Enter into This Industry
2.8 Global Quadrivalent Influenza Virus Split Vaccine Market Competitive Situation and Trends
2.8.1 Global Quadrivalent Influenza Virus Split Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Quadrivalent Influenza Virus Split Vaccine Players Market Share by Revenue
2.8.3 Global Quadrivalent Influenza Virus Split Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Quadrivalent Influenza Virus Split Vaccine Market Scenario by Region
3.1 Global Quadrivalent Influenza Virus Split Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Quadrivalent Influenza Virus Split Vaccine Sales by Region: 2020-2031
3.2.1 Global Quadrivalent Influenza Virus Split Vaccine Sales by Region: 2020-2025
3.2.2 Global Quadrivalent Influenza Virus Split Vaccine Sales by Region: 2026-2031
3.3 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Region: 2020-2031
3.3.1 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Region: 2020-2025
3.3.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Region: 2026-2031
3.4 North America Quadrivalent Influenza Virus Split Vaccine Market Facts & Figures by Country
3.4.1 North America Quadrivalent Influenza Virus Split Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Quadrivalent Influenza Virus Split Vaccine Sales by Country (2020-2031)
3.4.3 North America Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Quadrivalent Influenza Virus Split Vaccine Market Facts & Figures by Country
3.5.1 Europe Quadrivalent Influenza Virus Split Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Quadrivalent Influenza Virus Split Vaccine Sales by Country (2020-2031)
3.5.3 Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Quadrivalent Influenza Virus Split Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Quadrivalent Influenza Virus Split Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Quadrivalent Influenza Virus Split Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Quadrivalent Influenza Virus Split Vaccine Market Facts & Figures by Country
3.7.1 Latin America Quadrivalent Influenza Virus Split Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Quadrivalent Influenza Virus Split Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Quadrivalent Influenza Virus Split Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Quadrivalent Influenza Virus Split Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Quadrivalent Influenza Virus Split Vaccine Sales by Type (2020-2031)
4.1.1 Global Quadrivalent Influenza Virus Split Vaccine Sales by Type (2020-2025)
4.1.2 Global Quadrivalent Influenza Virus Split Vaccine Sales by Type (2026-2031)
4.1.3 Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2020-2031)
4.2.1 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2020-2025)
4.2.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2026-2031)
4.2.3 Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Quadrivalent Influenza Virus Split Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Quadrivalent Influenza Virus Split Vaccine Sales by Application (2020-2031)
5.1.1 Global Quadrivalent Influenza Virus Split Vaccine Sales by Application (2020-2025)
5.1.2 Global Quadrivalent Influenza Virus Split Vaccine Sales by Application (2026-2031)
5.1.3 Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2020-2031)
5.2.1 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2020-2025)
5.2.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2026-2031)
5.2.3 Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Quadrivalent Influenza Virus Split Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hualan Biological Engineering
6.1.1 Hualan Biological Engineering Company Information
6.1.2 Hualan Biological Engineering Description and Business Overview
6.1.3 Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Product Portfolio
6.1.5 Hualan Biological Engineering Recent Developments/Updates
6.2 ADIMMUNE Corporation
6.2.1 ADIMMUNE Corporation Company Information
6.2.2 ADIMMUNE Corporation Description and Business Overview
6.2.3 ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Product Portfolio
6.2.5 ADIMMUNE Corporation Recent Developments/Updates
6.3 Jiangsu GDK Biotechnology
6.3.1 Jiangsu GDK Biotechnology Company Information
6.3.2 Jiangsu GDK Biotechnology Description and Business Overview
6.3.3 Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Product Portfolio
6.3.5 Jiangsu GDK Biotechnology Recent Developments/Updates
6.4 Shanghai Institute Of Biological Products
6.4.1 Shanghai Institute Of Biological Products Company Information
6.4.2 Shanghai Institute Of Biological Products Description and Business Overview
6.4.3 Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Product Portfolio
6.4.5 Shanghai Institute Of Biological Products Recent Developments/Updates
6.5 Changchun Lnstitute of Biological Products Co., Ltd.
6.5.1 Changchun Lnstitute of Biological Products Co., Ltd. Company Information
6.5.2 Changchun Lnstitute of Biological Products Co., Ltd. Description and Business Overview
6.5.3 Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Portfolio
6.5.5 Changchun Lnstitute of Biological Products Co., Ltd. Recent Developments/Updates
6.6 Wuhan Institute of Biological Products Co., Ltd.
6.6.1 Wuhan Institute of Biological Products Co., Ltd. Company Information
6.6.2 Wuhan Institute of Biological Products Co., Ltd. Description and Business Overview
6.6.3 Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Portfolio
6.6.5 Wuhan Institute of Biological Products Co., Ltd. Recent Developments/Updates
6.7 Sinovac Biotech
6.7.1 Sinovac Biotech Company Information
6.7.2 Sinovac Biotech Description and Business Overview
6.7.3 Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Product Portfolio
6.7.5 Sinovac Biotech Recent Developments/Updates
6.8 Chongqing Zhifei Biological Products
6.8.1 Chongqing Zhifei Biological Products Company Information
6.8.2 Chongqing Zhifei Biological Products Description and Business Overview
6.8.3 Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Product Portfolio
6.8.5 Chongqing Zhifei Biological Products Recent Developments/Updates
6.9 Sanofi Pasteur
6.9.1 Sanofi Pasteur Company Information
6.9.2 Sanofi Pasteur Description and Business Overview
6.9.3 Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Product Portfolio
6.9.5 Sanofi Pasteur Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Quadrivalent Influenza Virus Split Vaccine Industry Chain Analysis
7.2 Quadrivalent Influenza Virus Split Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Quadrivalent Influenza Virus Split Vaccine Production Mode & Process Analysis
7.4 Quadrivalent Influenza Virus Split Vaccine Sales and Marketing
7.4.1 Quadrivalent Influenza Virus Split Vaccine Sales Channels
7.4.2 Quadrivalent Influenza Virus Split Vaccine Distributors
7.5 Quadrivalent Influenza Virus Split Vaccine Customer Analysis
8 Quadrivalent Influenza Virus Split Vaccine Market Dynamics
8.1 Quadrivalent Influenza Virus Split Vaccine Industry Trends
8.2 Quadrivalent Influenza Virus Split Vaccine Market Drivers
8.3 Quadrivalent Influenza Virus Split Vaccine Market Challenges
8.4 Quadrivalent Influenza Virus Split Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Hualan Biological Engineering
ADIMMUNE Corporation
Shanghai Institute of Biological Products
SINOVAC BIOTECH
Chongqing Zhifei Biological Products
Jiangsu GDK Biotechnology
List of Tables
 Table 1. Global Quadrivalent Influenza Virus Split Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Quadrivalent Influenza Virus Split Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Quadrivalent Influenza Virus Split Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Quadrivalent Influenza Virus Split Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Quadrivalent Influenza Virus Split Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Quadrivalent Influenza Virus Split Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Quadrivalent Influenza Virus Split Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Quadrivalent Influenza Virus Split Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Quadrivalent Influenza Virus Split Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Influenza Virus Split Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Quadrivalent Influenza Virus Split Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Quadrivalent Influenza Virus Split Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Quadrivalent Influenza Virus Split Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Quadrivalent Influenza Virus Split Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Quadrivalent Influenza Virus Split Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Quadrivalent Influenza Virus Split Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Quadrivalent Influenza Virus Split Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Quadrivalent Influenza Virus Split Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Quadrivalent Influenza Virus Split Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Quadrivalent Influenza Virus Split Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Quadrivalent Influenza Virus Split Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Quadrivalent Influenza Virus Split Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Quadrivalent Influenza Virus Split Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Quadrivalent Influenza Virus Split Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Quadrivalent Influenza Virus Split Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Quadrivalent Influenza Virus Split Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Quadrivalent Influenza Virus Split Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Quadrivalent Influenza Virus Split Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Quadrivalent Influenza Virus Split Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Quadrivalent Influenza Virus Split Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Quadrivalent Influenza Virus Split Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Quadrivalent Influenza Virus Split Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Quadrivalent Influenza Virus Split Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Quadrivalent Influenza Virus Split Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Hualan Biological Engineering Company Information
 Table 71. Hualan Biological Engineering Description and Business Overview
 Table 72. Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Product
 Table 74. Hualan Biological Engineering Recent Developments/Updates
 Table 75. ADIMMUNE Corporation Company Information
 Table 76. ADIMMUNE Corporation Description and Business Overview
 Table 77. ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Product
 Table 79. ADIMMUNE Corporation Recent Developments/Updates
 Table 80. Jiangsu GDK Biotechnology Company Information
 Table 81. Jiangsu GDK Biotechnology Description and Business Overview
 Table 82. Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Product
 Table 84. Jiangsu GDK Biotechnology Recent Developments/Updates
 Table 85. Shanghai Institute Of Biological Products Company Information
 Table 86. Shanghai Institute Of Biological Products Description and Business Overview
 Table 87. Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Product
 Table 89. Shanghai Institute Of Biological Products Recent Developments/Updates
 Table 90. Changchun Lnstitute of Biological Products Co., Ltd. Company Information
 Table 91. Changchun Lnstitute of Biological Products Co., Ltd. Description and Business Overview
 Table 92. Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product
 Table 94. Changchun Lnstitute of Biological Products Co., Ltd. Recent Developments/Updates
 Table 95. Wuhan Institute of Biological Products Co., Ltd. Company Information
 Table 96. Wuhan Institute of Biological Products Co., Ltd. Description and Business Overview
 Table 97. Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product
 Table 99. Wuhan Institute of Biological Products Co., Ltd. Recent Developments/Updates
 Table 100. Sinovac Biotech Company Information
 Table 101. Sinovac Biotech Description and Business Overview
 Table 102. Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Product
 Table 104. Sinovac Biotech Recent Developments/Updates
 Table 105. Chongqing Zhifei Biological Products Company Information
 Table 106. Chongqing Zhifei Biological Products Description and Business Overview
 Table 107. Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Product
 Table 109. Chongqing Zhifei Biological Products Recent Developments/Updates
 Table 110. Sanofi Pasteur Company Information
 Table 111. Sanofi Pasteur Description and Business Overview
 Table 112. Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Product
 Table 114. Sanofi Pasteur Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Quadrivalent Influenza Virus Split Vaccine Distributors List
 Table 118. Quadrivalent Influenza Virus Split Vaccine Customers List
 Table 119. Quadrivalent Influenza Virus Split Vaccine Market Trends
 Table 120. Quadrivalent Influenza Virus Split Vaccine Market Drivers
 Table 121. Quadrivalent Influenza Virus Split Vaccine Market Challenges
 Table 122. Quadrivalent Influenza Virus Split Vaccine Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Quadrivalent Influenza Virus Split Vaccine
 Figure 2. Global Quadrivalent Influenza Virus Split Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Quadrivalent Influenza Virus Split Vaccine Market Share by Type: 2024 & 2031
 Figure 4. 0.5mL/Tube Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Quadrivalent Influenza Virus Split Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Quadrivalent Influenza Virus Split Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Influenza A Virus Prevention
 Figure 9. Influenza B Virus Prevention
 Figure 10. Global Quadrivalent Influenza Virus Split Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Quadrivalent Influenza Virus Split Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Quadrivalent Influenza Virus Split Vaccine Sales (2020-2031) & (K Units)
 Figure 13. Global Quadrivalent Influenza Virus Split Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Quadrivalent Influenza Virus Split Vaccine Report Years Considered
 Figure 15. Quadrivalent Influenza Virus Split Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Quadrivalent Influenza Virus Split Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Quadrivalent Influenza Virus Split Vaccine Players: Market Share by Revenue in Quadrivalent Influenza Virus Split Vaccine in 2024
 Figure 18. Quadrivalent Influenza Virus Split Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Quadrivalent Influenza Virus Split Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Quadrivalent Influenza Virus Split Vaccine by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Quadrivalent Influenza Virus Split Vaccine by Type (2020-2031)
 Figure 52. Global Quadrivalent Influenza Virus Split Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Quadrivalent Influenza Virus Split Vaccine by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Quadrivalent Influenza Virus Split Vaccine by Application (2020-2031)
 Figure 55. Global Quadrivalent Influenza Virus Split Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 56. Quadrivalent Influenza Virus Split Vaccine Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions